Use of sacubitril/valsartan in Marfan syndrome–related cardiomyopathy: The first case report

RATIONALE: Marfan syndrome is a rare cause of heart failure due to primary or secondary cardiomyopathy. Recently, sacubitril/valsartan—an angiotensin receptor blocker-neprilysin inhibitor—has been added in clinical practice as a standard therapy for heart failure. To our knowledge, there are no data...

Descripción completa

Detalles Bibliográficos
Autores principales: Spoto, Silvia, Valeriani, Emanuele, Locorriere, Luciana, Anguissola, Giuseppina Beretta, Pantano, Angelo Lauria, Terracciani, Francesca, Bono, Maria Caterina, Costantino, Sebastiano, Ciccozzi, Massimo, Angeletti, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882602/
https://www.ncbi.nlm.nih.gov/pubmed/31764806
http://dx.doi.org/10.1097/MD.0000000000017978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882602/
https://www.ncbi.nlm.nih.gov/pubmed/31764806
http://dx.doi.org/10.1097/MD.0000000000017978

Ejemplares similares